NorthRock Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$524K Buy
6,193
+222
+4% +$17.9K 0.01% 429
2026
Q1
$422K Buy
+5,971
New +$447K 0.01% 441
2025
Q4
Sell
-14,358
Closed -$1.18M 800
2025
Q3
$1.18M Buy
14,358
+4,607
+47% +$363K 0.02% 312
2025
Q2
$784K Buy
9,751
+2,366
+32% +$183K 0.02% 298
2025
Q1
$593K Buy
7,385
+8
+0.1% +$665 0.02% 311
2024
Q4
$604K Buy
7,377
+34
+0.5% +$2.83K 0.02% 305
2024
Q3
$606K Sell
7,343
-446
-6% -$33.3K 0.02% 323
2024
Q2
$547K Sell
7,789
-661
-8% -$47.2K 0.02% 320
2024
Q1
$626K Sell
8,450
-1,296
-13% -$90.3K 0.02% 301
2023
Q4
$645K Buy
+9,746
New +$610K 0.03% 260
2023
Q1
Sell
-5,039
Closed -$365K 350
2022
Q4
$365K Buy
5,039
+343
+7% +$24.6K 0.04% 209
2022
Q3
$285K Sell
4,696
-2,649
-36% -$169K 0.03% 211
2022
Q2
$461K Buy
7,345
+3,113
+74% +$206K 0.05% 164
2022
Q1
$297K Buy
+4,232
New +$286K 0.03% 245

Other funds holding MET

NorthRock Partners's MET Position: Q2 2026 in Review

NorthRock Partners increased its MetLife (MET) stake by 3.7% in Q2 2026, buying an estimated $17.9K and bringing the position to 6,193 shares worth $524K. The position accounts for 0.01% of the portfolio, ranked #429.

NorthRock Partners first reported a position in MET in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.18M in Q3 2025. 1,448 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • NorthRock Partners held 6,193 shares of MetLife worth $524K as of Q2 2026.
  • NorthRock Partners bought 222 MetLife shares in Q2 2026, an estimated $17.9K.
  • MetLife made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #429 holding.
  • NorthRock Partners first reported a position in MetLife in Q1 2022 and has held it in 14 quarters since.
  • NorthRock Partners's MetLife position peaked at $1.18M in Q3 2025.
  • 1,448 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.